Treating psoriasis patients with biologic agents.
Pariser
David M
DM
Department of Dermatology, Eastern Virginia Medical School, 601 Medical Tower, Norfolk, VA 23507, USA. dpariser@pariserderm.com
D000911:Antibodies, Monoclonal / Q000008:administration & dosage* / Q000493:pharmacokinetics; D015703:Antigens, CD / Q000187:drug effects / Q000276:immunology; D003879:Dermatologic Agents / Q000008:administration & dosage* / Q000493:pharmacokinetics; D004341:Drug Evaluation; D004502:Education, Medical, Continuing; D004513:Education, Pharmacy, Continuing; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage* / Q000493:pharmacokinetics; D011565:Psoriasis / Q000188:drug therapy* / Q000276:immunology* / Q000503:physiopathology; D011948:Receptors, Antigen, T-Cell / Q000187:drug effects / Q000276:immunology; D011993:Recombinant Fusion Proteins / Q000008:administration & dosage* / Q000493:pharmacokinetics
D000911:Antibodies, Monoclonal; D015703:Antigens, CD; D003879:Dermatologic Agents; D007166:Immunosuppressive Agents; D011948:Receptors, Antigen, T-Cell; D011993:Recombinant Fusion Proteins